Tender Details
Ref No 23868041
Document

Tender Notice

Bidding

Not specified

Short Description

Oranges Are Fresh; Fresh Cucumbers; Fresh Tomatoes; Fresh Bananas, First Grade, Green, From 20 Cm, Fruit Diameter No More Than 4 Cm; Table Beet Of The First Commercial Grade, 5-10 Cm, Dstu 7033; White Cabbage, Fresh, Late Ripening, Of The First Commercial Grade, Dstu 7037; Fresh Cauliflower, Of The First Commercial Grade, Dst 3280; Beijing Cabbage, Fresh, Of The First Commercial Grade; Fresh Carrots, Of The First Commercial Grade, Dstu 7035; Kiwi, Higher Grade, Fruit Weighing At Least 90 G; Fres
Deadline *
Date 27 Jan 2026
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Ukraine
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

  • Ref No: 5307616
  • Location: Netherlands

Career Paths Transport And Logistics

  • Deadline: 30 Apr 2026
  • Ref No: 5837360
  • Location: Germany

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Blood Sugar Test Strips

  • Deadline: 10 May 2026
  • Ref No: 5227070
  • Location: Germany

Medicines With The Active Ingredient Dupilumab Atc D11Ah05

  • Deadline: 31 Mar 2026
  • Ref No: 5229599
  • Location: Germany

Medicines With The Active Ingredient Fampridine Atc N07Xx07

  • Deadline: 31 Mar 2026
  • Ref No: 5965414
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Acarbose Not In Standard Size

  • Deadline: 10 May 2026
  • Ref No: 8267412
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Brinzolamide Brimonidine Atr

  • Deadline: 10 May 2026
  • Ref No: 8294730
  • Location: Germany

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Omalizumab

  • Deadline: 10 Aug 2026
  • Ref No: 8309306
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pomalidomide

  • Deadline: 10 May 2026
  • Ref No: 8312368
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bosutinib

  • Deadline: 10 May 2026
  • Ref No: 5716614
  • Location: Germany

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Rituximab

  • Deadline: 11 May 2026
  • Ref No: 5718497
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

  • Deadline: 11 May 2026
  • Ref No: 5728730
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

  • Deadline: 10 May 2026
  • Ref No: 5730369
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ranibizumab

  • Deadline: 10 May 2026
  • Ref No: 6596413
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Quinine

  • Deadline: 10 May 2026
  • Ref No: 6591825
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Clobazam

  • Deadline: 10 May 2026
WhatsApp Chat